Showing 481 - 500 results of 743 for search '"chronic kidney disease"', query time: 0.13s Refine Results
  1. 481

    Reporting and interpreting statistical results in veterinary medicine: Calling for change by Hsin‐Yi Weng, Locksley L. McV. Messam

    Published 2025-01-01
    “…We utilize a hypothetical randomized controlled trial of dietary management in cats with chronic kidney disease to discuss some common misconceptions about P values and provide practical suggestions for alternatives. …”
    Get full text
    Article
  2. 482

    Potentially paraneoplastic glomerulopathies in a Brazilian cohort: a retrospective analysis by Marcella Soares Laferreira, Gianna Mastroianni Kirsztajn

    Published 2025-01-01
    “…Progression to chronic kidney disease stage 5 at the end of follow-up occurred in 8.4% of the cases. …”
    Get full text
    Article
  3. 483

    Diabetic Muscle Infarction: A Rare Cause of Acute Limb Pain in Dialysis Patients by G. De Vlieger, B. Bammens, F. Claus, R. Vos, K. Claes

    Published 2013-01-01
    “…Diabetic patients with chronic kidney disease stage Vd are prone to develop this complication. …”
    Get full text
    Article
  4. 484

    Tranexamic Acid Treatment of Life-Threatening Hematuria in Polycystic Kidney Disease by Turki AlAmeel, Michael West

    Published 2011-01-01
    “…A 41-year-old woman with autosomal dominant polycystic kidney disease had chronic kidney disease class IV. She presented 10 days postpartum with a 4-day history of severe hematuria, left flank pain, and anemia, hemoglobin 62 g/L. …”
    Get full text
    Article
  5. 485

    Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease by Damir Rebić, Senija Rašić, Velma Rebić

    Published 2013-01-01
    “…Vascular diseases are the most common cause of morbidity and mortality in the chronic kidney disease. The aim of this study was to analyze the impact of peritoneal dialysis (PD) treatment on morphologic and hemodynamic vascular parameters of carotid arteries in diabetic type 2 and nondiabetic patients with ESRD during the period of one year after the start of PD treatment using ultrasonography of carotid arteries and their relation on uremia and PD inherent factors. …”
    Get full text
    Article
  6. 486

    Depresi sebagai Prediksi Kematian dalam 1 Tahun pada Pasien Hemodialisis by Langgeng Perdhana, Shofa Chasani, Siti Nuraini

    Published 2022-01-01
    “…Meanwhile, those whose data were incomplete, transferred to another hemodialysis unit, HBSAg +, and had other stressors unrelated to hemodialysis or Chronic Kidney Disease (CKD) were excluded from this study. …”
    Get full text
    Article
  7. 487

    Phenotypic variability and the gender paradox in the R363C variant of Fabry disease by Alison C. Leslie, Jeanine Jarnes, Alia Ahmed, Sofia Shrestha, Jeffrey Wang, Chester B. Whitley, Nishitha R. Pillai

    Published 2025-01-01
    “…A family is presented here with a 36‐year‐old female who is symptomatic with chronic kidney disease and her oligosymptomatic 70‐year‐old father, both of whom have a heterozygous and hemizygous GLA pathogenic variant, respectively, c.1087C>T (p.R363C). …”
    Get full text
    Article
  8. 488

    Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study. by Elena K Joerns, Michelle A Ghebranious, Traci N Adams, Una E Makris

    Published 2025-01-01
    “…<h4>Results</h4>History of cerebrovascular accident (CVA) or cardiovascular disease (CVD), moderate-severe chronic kidney disease, and fracture was associated with a faster onset of lung disease progression, while a history of gastroesophageal reflux was protective. …”
    Get full text
    Article
  9. 489

    Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge by Wenyi Gu, Wenyi Gu, Jiajing Zhao, Yu Xu, Yu Xu, Yu Xu

    Published 2025-01-01
    “…Characterized by elevated levels of UA, HUA has become an independent risk factor for gout, chronic kidney disease, insulin resistance, cardiovascular disease, nonalcoholic fatty liver disease, etc. …”
    Get full text
    Article
  10. 490

    Economic analysis of hemodialysis and urgent-start peritoneal dialysis therapies by Alexandre Minetto Brabo, Dayana Bitencourt Dias, Everton Nunes da Silva, Daniela Ponce

    Published 2025-01-01
    “…Abstract Introduction: Unplanned initiation of renal replacement therapy (RRT) in chronic kidney disease (CKD) patients is a common situation worldwide. …”
    Get full text
    Article
  11. 491

    Hypertension-Related Admissions and Outcome in a Tertiary Hospital in Northeast Nigeria by P. M. Kolo, Y. B. Jibrin, E. O. Sanya, M. Alkali, I. B. Peter Kio, R. K. Moronkola

    Published 2012-01-01
    “…Stroke had the highest mortality (39.3%), followed by chronic kidney disease (36.6%); hypertensive emergencies (30.9%) and hypertensive heart failure had the lowest intrahospital mortality (27.5%). …”
    Get full text
    Article
  12. 492

    Severe Disabling Myalgia as an Initial Presentation of Polyarteritis Nodosa by H. M. Senarathna, C. L. Fonseka, H. A. S. Perera, P. U. T. De Silva, T. P. Weerarathna

    Published 2019-01-01
    “…We present a case of 54-year-old male with recently detected chronic kidney disease admitted with progressive severe disabling muscular pains predominantly over calves with constitutional symptoms for seven weeks. …”
    Get full text
    Article
  13. 493

    Coexistent Pseudogout and Mycobacterium avium-intracellulare Septic Arthritis in a Patient with HIV and ESRD by Wais Afzal, Omer M. Wali, Kelly L. Cervellione, Bhupinder B. Singh, Farshad Bagheri

    Published 2016-01-01
    “…Although not very common, this entity can be seen in patients with chronic kidney disease (CKD). Septic arthritis due to Mycobacterium avium-intracellulare (MAI) is a rare entity that can affect immunocompromised patients such as those with acquired immunodeficiency syndrome (AIDS) or those who are on immunosuppressive drugs. …”
    Get full text
    Article
  14. 494

    A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy by Christina Soeun Kwon, Patrick Daniele, Anna Forsythe, Christopher Ngai

    Published 2021-09-01
    “…Relative to Europe, the United States had more patients diagnosed with IgAN in later chronic kidney disease stages. US rates of transition to end-stage renal disease (ESRD) ranged from 12.5% to 23% during 3-3.9 years of observation, rising to 53% during 19 years of observation. …”
    Get full text
    Article
  15. 495

    Incidence of Dysmagnesemia among Medically Hospitalized Patients and Associated Clinical Characteristics: A Prospective Cohort Study by Zahra Al Shukri, Juhaina Salim Al-Maqbali, Abdullah M. Al Alawi, Nafila Al Riyami, Sulaiman Al Riyami, Hiba Al Alawi, Qatiba Al Farai, Henrik Falhammar

    Published 2023-01-01
    “…Statistically significant associations were identified between hypermagnesemia and chronic kidney disease (CKD) (p = 0.05) and elevated creatinine levels (p < 0.01) and lower estimated glomerular filtration rate (eGFR) (p < 0.01). …”
    Get full text
    Article
  16. 496

    Bisphophonates in CKD Patients with Low Bone Mineral Density by Wen-Chih Liu, Jen-Fen Yen, Cheng-Lin Lang, Ming-Tso Yan, Kuo-Cheng Lu

    Published 2013-01-01
    “…Patients with chronic kidney disease-mineral and bone disorder (CKD-MBD) have a high risk of bone fracture because of low bone mineral density and poor bone quality. …”
    Get full text
    Article
  17. 497

    Interaction studies unveil potential binding sites on bovine serum albumin for gut metabolite trimethylamine n-oxide (TMAO) by Awadhesh Kumar Verma, Payal Gulati, GBVS Lakshmi, Anand Mohan, Neeta Raj Sharma, Pratima R. Solanki, Anil Kumar

    Published 2025-01-01
    “…These findings provide a foundation for understanding the pharmacodynamics and pharmacokinetics of TMAO and may aid in developing strategies for treating diseases, such as chronic kidney disease and neurological disorder where TMAO-serum albumins interaction are implicated.…”
    Get full text
    Article
  18. 498

    Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies by Anna P. Kempke, Abbie S. Leino, Farzad Daneshvar, John Andrew Lee, Bruce A. Mueller

    Published 2016-01-01
    “…A literature search of PubMed, Micromedex, and Embase was conducted for 40 drugs commonly used in the ICU to gather pharmacokinetic data acquired from patients with acute and chronic kidney disease as well as healthy volunteers. These data and that obtained from drug package inserts were gathered for use in three published CRRT drug dosing equations. …”
    Get full text
    Article
  19. 499
  20. 500

    Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19 by Dogan Mustafa, Yilmaz Berna

    Published 2023-06-01
    “…In addition to being unvaccinated, advanced age, coronary artery disease (CAD), diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), and obesity were found to be associated with higher mortality risk. …”
    Get full text
    Article